Global Medical REIT (NYSE:XRN) CEO Purchases $287,040.00 in Stock

Global Medical REIT Inc. (NYSE:XRN) CEO Mark Okey Decker, Jr. acquired 8,000 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were bought at an average price of $35.88 per share, for a total transaction of $287,040.00. Following the purchase, the chief executive officer directly owned 67,774 shares of the company’s stock, valued at approximately $2,431,731.12. This trade represents a 13.38% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Global Medical REIT Price Performance

Shares of NYSE:XRN opened at $37.28 on Friday. The stock has a market cap of $493.59 million, a price-to-earnings ratio of 10.02 and a beta of 1.09. The company has a debt-to-equity ratio of 1.37, a current ratio of 0.59 and a quick ratio of 0.68. Global Medical REIT Inc. has a 12 month low of $29.05 and a 12 month high of $39.93. The stock’s 50 day moving average price is $36.62 and its 200 day moving average price is $35.81.

Global Medical REIT (NYSE:XRN) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $4.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $3.95. Global Medical REIT had a return on equity of 13.31% and a net margin of 36.82%.The firm had revenue of $39.75 million during the quarter. Equities research analysts anticipate that Global Medical REIT Inc. will post 2.89 earnings per share for the current fiscal year.

Global Medical REIT News Roundup

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: CEO Mark Okey Decker, Jr. bought 8,000 shares at $35.88 and an additional 6,875 shares at $35.92, while COO Aaron Robert Roseth purchased 13,500 shares at $36.73. Director Charles Fitzgerald also acquired 14,000 shares at $35.78. The reported purchases represent more than $1.5 million of direct insider buying, a potentially bullish signal. Global Medical REIT CEO Purchases Shares
• Positive Sentiment: Global Medical REIT’s latest quarterly results significantly exceeded expectations: earnings per share were $4.78 versus the $0.83 consensus estimate, with revenue of $39.75 million. The company also reported a 36.82% net margin and 13.74% return on equity, providing fundamental support for investor interest.
• Neutral Sentiment: Analyst opinion remains mixed, with two Buy ratings, five Holds and one Sell. The average price target is $40.25, above the recent trading range, but Compass Point maintains a $38 target while Citizens JMP has a $42 target. The overall consensus rating is Hold.
• Neutral Sentiment: Institutional investors own approximately 57.52% of XRN. Recent filings show several funds increasing positions, although the disclosed transactions are not necessarily a near-term catalyst.
• Neutral Sentiment: Coverage also discusses Global Medical REIT’s rebranding and transition to Chiron Real Estate, which may create uncertainty about the company’s identity and strategic direction. Chiron Real Estate rebrand article
• Negative Sentiment: The REIT remains relatively leveraged, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68. High debt and limited liquidity could weigh on valuation if interest rates stay elevated or healthcare property conditions weaken.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. BMO Capital Markets upped their price target on shares of Global Medical REIT from $39.00 to $40.00 and gave the company a “market perform” rating in a report on Monday, July 13th. Compass Point reiterated a “neutral” rating and issued a $38.00 target price (down from $50.00) on shares of Global Medical REIT in a report on Thursday, May 7th. Wall Street Zen cut shares of Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Raymond James Financial initiated coverage on shares of Global Medical REIT in a research report on Wednesday, June 17th. They issued a “market perform” rating on the stock. Finally, Zacks Research upgraded Global Medical REIT to a “hold” rating in a research report on Wednesday, July 22nd. Two investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $40.25.

Institutional Trading of Global Medical REIT

Several institutional investors and hedge funds have recently bought and sold shares of XRN. Invesco Ltd. lifted its stake in Global Medical REIT by 30.5% during the second quarter. Invesco Ltd. now owns 1,518,668 shares of the company’s stock valued at $10,524,000 after buying an additional 355,355 shares in the last quarter. Alyeska Investment Group L.P. purchased a new position in shares of Global Medical REIT in the third quarter worth approximately $9,997,000. Marshall Wace LLP increased its position in shares of Global Medical REIT by 2,208.2% in the second quarter. Marshall Wace LLP now owns 291,708 shares of the company’s stock worth $2,022,000 after acquiring an additional 279,070 shares in the last quarter. Heartland Advisors Inc. raised its holdings in shares of Global Medical REIT by 177.4% during the fourth quarter. Heartland Advisors Inc. now owns 423,460 shares of the company’s stock valued at $14,288,000 after acquiring an additional 270,786 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC acquired a new stake in shares of Global Medical REIT during the third quarter valued at approximately $7,798,000. Institutional investors and hedge funds own 57.52% of the company’s stock.

About Global Medical REIT

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.